A Comparison of the effect of lidocaine, articaine and mepivacaine on pulpal anesthesia in maxillary molars with irreversible pulpitis

A Comparison of the effect of lidocaine, articaine and mepivacaine on pulpal anesthesia in maxillary molars with irreversible pulpitis (double-blind randomized trial)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220226054132N1

Enrollment

114

Registered

2022-03-06

Start date

2022-04-02

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irreversible pulpitis. Streptococcus, Staphylococcus, and Enterococcus as the cause of diseases classified elsewhere

Interventions

The first intervention group: lidocaine receiving group - the second intervention group: articaine receiving group - the third intervention group: mipivacaine receiving group.

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: people must have irreversible pulpitis in maxillary molar

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Answer to electronic pulp tester and cold test. Timepoint: 2, 4, 6, 8 and 10 minutes. Method of measurement: Using the electronic pulp tester and increasing its degree from 0 to 8, if the tooth does not feel numb, and using a cotton ball on which the cold spray is sprayed and the buccal side of the tooth is studied for up to 10 seconds.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarhad Jamali

Rasht University of Medical Sciences

farhadja.a@gmail.com+98 13 3340 2051

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026